Organisation paid for research Program year 2025 Source: CMS Open Payments

Upstate Clinical Trials LLC

Neither a doctor nor a teaching hospital

Research payments

$340,157

356 payments

Through program year 2025, Upstate Clinical Trials LLC is reported as receiving $340,157 in research payments, across 356 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $3,520 7
2024 Research $4,359 3
2023 Research $290 2
2022 Research $46,971 81
2021 Research $56,350 53
2020 Research $164,792 199
2019 Research $63,873 11

Breakdown

Who paid Research payments · program years 2019–2025
  1. Alcon Research LLC $231,786 326 payments
  2. Abbott Laboratories $52,698 6 payments
  3. Novartis Pharmaceuticals Corporation $40,472 11 payments
  4. Saluda Medical Americas, Inc. $7,500 8 payments
  5. GRT US Holding, Inc. $4,570 2 payments
  6. Medtronic USA, Inc. $3,104 2 payments
  7. Scilex Pharmaceuticals Inc. $26 1 payment
Studies the money was for Research payments · program years 2019–2025
  1. Mercury Extended Wear Registration Trial(Weekly SiHy NW Sphere (Mercury)) $108,577 166 payments
  2. Clinical Assessment of Two Reusable Silicone Hydrogel Contact Lenses $66,858 100 payments
  3. MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator $40,980 4 payments
  4. Clinical Evaluation of a Silicone Hydrogel Daily Wear Monthly Replacement Contact Lens $37,440 39 payments
  5. An Open Label Single Arm Multi Center Extension Study Evaluating Long Term Safety Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis $28,849 8 payments
  6. Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens $18,912 21 payments
  7. MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator $11,718 2 payments
  8. Long Term Prospective Multinational Parallel Cohort Study Monitoring Safety in Patients With Multiple Sclerosis Newly Started With Fingolimod Once Daily Or Treated With Another Approved Disease Modifying Therapy $11,623 3 payments
  9. Neural Panel $7,500 8 payments
  10. Kf7013-02 $4,570 2 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $26 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record